News
Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...
Galapagos reported promising results from ATALANTA-1 study show 100% ORR/CR for relapsed Mantle Cell Lymphoma. Click for GLPG ...
Comments by U.S. health secretary Robert F. Kennedy Jr. have mobilized the autism community to dispel misconceptions about ...
A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...
IDLProcycling on MSN1d
Lidl-Trek's manager shares his moving story about living with lymphoma: "When you see that love..."While there are many stories about medical incidents and crashes involving riders in cycling, team managers can also be ...
The artist-provocateur reverse-engineered the blue-green shade called ‘olo.’ Now you can buy it as an acrylic paint.
Everyone in the room stood when asked if they had cancer or lost a loved one, friend, or neighbor to the deadly disease.
In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...
During a live event, Nathan M. Denlinger, DO, MS, discussed the TRANSFORM trial of lisocabtagene maraleucel in B-cell ...
The actor and comedian is also recalling how he nearly "killed the moment" with a joke in the family group chat.
Welsh rock band The Alarm followed in the footsteps of their friends U2, rising out of the fertile late 70s UK post punk ...
During a live event, Caron A. Jacobson, MD, MMSc, and participants discussed how they decide on therapy for patients with relapsed/refractory diffuse large B-cell lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results